What does this research mean for the field?

In patients with Type 2 Diabetes Mellitus, polypharmacy significantly increases with age and comorbidity burden, and while general prescribing aligns with guidelines, newer cardioprotective and renoprotective agents like SGLT2 inhibitors and GLP-1 receptor agonists remain underutilized. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To explore the link between comorbidity patterns and the use of specific medications in patients with type 2 diabetes mellitus.

June 20, 2026Journal of Integrated Health SciencesOpen Access

Association of Comorbidity Patterns with the Utilization of Comorbidity-specific Medications in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study

View Full Paper

Ask AI

Bookmark

Authors

SRSK Sabir Rahaman RBRAJAT KANTI BISWAS APAnanya Pal

Discussion

Member takes

Overview

Cross-sectional study evaluates medication use related to comorbidities in Type 2 Diabetes, suggesting areas for improvement.

Key Points

To explore the link between comorbidity patterns and the use of specific medications in patients with type 2 diabetes mellitus.
Cross-sectional study conducted from July 2022 to September 2023 with 150 adults with T2DM.
Data extracted from hospital records and prescriptions reviewed for medication appropriateness.
Statistical analyses included Chi-square, ANOVA, and logistic regression.
Dyslipidemia (79.3%) and hypertension (48.7%) were the most common comorbidities.
Logistic regression showed ≥2 comorbidities (OR 4.3, P < 0.001) and age ≥60 (OR 2.1, P = 0.01) as predictors of polypharmacy.
Low uptake of cardioprotective drugs associated with cardiovascular/renal disease (OR 3.5, P = 0.03).

Cite This Study

Rahaman et al. (2026) studied this question.

synapsesocial.com/papers/6a362f3bdb0793dc1a536ca2 https://doi.org/10.4103/jihs.jihs_90_25

View Full Paper

Ask AI

Bookmark

June 20, 2026Journal of Integrated Health SciencesOpen Access

Association of Comorbidity Patterns with the Utilization of Comorbidity-specific Medications in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study

View Full Paper

Ask AI

Bookmark

Authors

SRSK Sabir Rahaman RBRAJAT KANTI BISWAS APAnanya Pal

Discussion

Member takes

Overview

Cross-sectional study evaluates medication use related to comorbidities in Type 2 Diabetes, suggesting areas for improvement.

Key Points

To explore the link between comorbidity patterns and the use of specific medications in patients with type 2 diabetes mellitus.
Cross-sectional study conducted from July 2022 to September 2023 with 150 adults with T2DM.
Data extracted from hospital records and prescriptions reviewed for medication appropriateness.
Statistical analyses included Chi-square, ANOVA, and logistic regression.
Dyslipidemia (79.3%) and hypertension (48.7%) were the most common comorbidities.
Logistic regression showed ≥2 comorbidities (OR 4.3, P < 0.001) and age ≥60 (OR 2.1, P = 0.01) as predictors of polypharmacy.
Low uptake of cardioprotective drugs associated with cardiovascular/renal disease (OR 3.5, P = 0.03).

Cite This Study

Rahaman et al. (2026) studied this question.

synapsesocial.com/papers/6a362f3bdb0793dc1a536ca2 https://doi.org/10.4103/jihs.jihs_90_25

View Full Paper

Ask AI

Bookmark